Cardiomyocyte-specific knockout of ADAM17 alleviates doxorubicin-induced cardiomyopathy via inhibiting TNFα–TRAF3–TAK1–MAPK axisLin Xie, Yun Zhang, Peili Bu et al.|Signal Transduction and Targeted Therapy|2024Cited by 34